Literature DB >> 34793197

Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies.

Akaash K Mishra1, Jan Hellert2, Natalia Freitas3, Pablo Guardado-Calvo2, Ahmed Haouz4, J Maximilian Fels5, Daniel P Maurer6, Dafna M Abelson7, Zachary A Bornholdt7, Laura M Walker6, Kartik Chandran5, François-Loïc Cosset3, Jason S McLellan1, Felix A Rey2.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is the most widespread tick-borne zoonotic virus, with a 30% case fatality rate in humans. Structural information is lacking in regard to the CCHFV membrane fusion glycoprotein Gc—the main target of the host neutralizing antibody response—as well as antibody–mediated neutralization mechanisms. We describe the structure of prefusion Gc bound to the antigen-binding fragments (Fabs) of two neutralizing antibodies that display synergy when combined, as well as the structure of trimeric, postfusion Gc. The structures show the two Fabs acting in concert to block membrane fusion, with one targeting the fusion loops and the other blocking Gc trimer formation. The structures also revealed the neutralization mechanism of previously reported antibodies against CCHFV, providing the molecular underpinnings essential for developing CCHFV–specific medical countermeasures for epidemic preparedness.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34793197     DOI: 10.1126/science.abl6502

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  2 in total

Review 1.  Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.

Authors:  Lynda Coughlan; Eric J Kremer; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

2.  The structure of Crimean-Congo hemorrhagic fever virus Gc is revealed; many more still need an answer.

Authors:  Wei Ye; Chuantao Ye; Yongliang Hu; Yangchao Dong; Yingfeng Lei; Fanglin Zhang
Journal:  Virol Sin       Date:  2022-05-14       Impact factor: 6.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.